Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stanford researcher studies newly discovered ’good’ cholesterol gene

04.02.2003


Stanford University Medical Center researchers have found that a recently discovered gene regulates HDL (high density lipoproteins) cholesterol, also known as "good" cholesterol. The study, published in the February issue of the Journal of Clinical Investigation, could lead to new therapies for heart disease, said lead author Thomas Quertermous, MD.



"This is a significant and unexpected finding, and the gene is going to be a real target for the prevention and treatment of heart disease," said Quertermous, the William G. Irwin Professor and chief of cardiovascular medicine at Stanford University School of Medicine. "This type of thing doesn’t happen every day."

HDL cholesterol, often referred to as the "good" cholesterol, has been proven to impact a person’s risk of developing heart disease. "HDL cholesterol is an independent predictor of one’s risk," said Quertermous. "If you have a high level of HDL cholesterol your chance of getting heart disease is very low."


Researchers know that levels of HDL cholesterol are regulated in part by members of the lipase gene family. Three years ago, Quertermous’ team and a laboratory on the East Coast simultaneously discovered the newest member of that family and found that its protein was expressed in a variety of tissues. Subsequent studies showed that the new gene - the endothelial lipase gene (LIPG) - played a role in lipid metabolism.

"It was a striking, if not dramatic, finding that this gene that we found in the blood vessel walls appeared to regulate HDL cholesterol levels," said Quertermous.

Quertermous’ team sought to examine the gene’s exact role in regulating HDL cholesterol level by examining genetic models with altered levels of endothelial lipase (EL) expression. Working with mouse models, the researchers increased EL expression in one group by inserting copies of the human gene and decreased EL expression by knocking out the LIPG gene in another group.

Quertermous reports that the findings were striking: Altering the genes showed a clear and significant inverse relationship between HDL cholesterol level and EL expression. Levels of HDL cholesterol decreased by 19 percent in the first group and increased by 57 percent in the group whose gene was knocked out.

"When we overexpressed the human gene in the mice, the HDL cholesterol levels dropped," said Quertermous. "Conversely, when we knocked out the gene in mice, the levels were much higher."

Quertermous said that his team lacks insight into the mechanism by which EL impacts HDL cholesterol levels, and that this is something his team will explore. The group will also further study mouse models, and a group of human patients, to see if changes in HDL cholesterol levels directly correlate with heart disease. "My hypothesis - and strong suspicion - is that if you knock out the gene, your chance of disease development is decreased," said Quertermous.

Quertermous said a greater understanding of this gene’s role in HDL cholesterol’s formation and metabolism will help researchers regulate this risk factor. "This becomes one of the most attractive targets available for the development of pharmaceutical agents to modulate HDL cholesterol levels," he said.


The research was done at the Donald W. Reynolds Cardiovascular Clinical Research Center at Stanford, which was established with a grant from the Donald W. Reynolds Foundation. Quertermous’ collaborators on the study include Allen Cooper, MD, professor of medicine at Stanford, and researchers at the Palo Alto Medical Foundation.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. For more information, please visit the Web site of the medical center’s Office of Communication & Public Affairs at http://mednews.stanford.edu.

PRINT MEDIA CONTACT: Michelle Brandt at (650) 723-0272 (mbrandt@stanford.edu)
BROADCAST MEDIA CONTACT: Neale Mulligan at (650) 724-2454 (nealem@stanford.edu)

Michelle Brandt | EurekAlert!
Further information:
http://mednews.stanford.edu

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>